I. Wakabayashi et al., INHIBITORY EFFECTS OF DAUNORUBICIN ON ENDOTHELIUM-DEPENDENT VASORELAXING RESPONSE TO ACETYLCHOLINE OF RAT AORTA, Journal of Pharmacy and Pharmacology, 46(4), 1994, pp. 296-299
The effect of daunorubicin on the endothelium-dependent vasorelaxing r
esponse to acetylcholine was investigated using rat isolated aorta and
compared with the effect of aclarubicin. Treatment of aortic strips w
ith daunorubicin (20 mu M) significantly attenuated the relaxing respo
nse to acetylcholine in the absence of tetraethylammonium, but not in
its presence. Pretreatment with daunorubicin at a higher concentration
(50 mu M) or with aclarubicin (20 mu M) strongly attenuated the relax
ing response to acetylcholine; this attenuation was unaffected by the
presence of tetraethylammonium. The increase in aortic cGMP in respons
e to acetylcholine was also significantly suppressed by pretreatment w
ith 50 mu M daunorubicin or 20 mu M aclarubicin, but not by treatment
with 20 mu M daunorubicin. The inhibitory effect of 20 mu M aclarubici
n on the acetylcholine-induced responses was stronger than that of 50
mu M daunorubicin. Even in strips pretreated with both 50 mu M daunoru
bicin and 20 mu M aclarubicin, relaxation induced by 0 1 mu M sodium n
itroprusside was retained. These results suggest that daunorubicin at
20 mu M inhibits the endothelium-dependent vasorelaxing response to ac
etylcholine via a mechanism other than the nitric oxide-mediated pathw
ay, whilst at 50 mu M, it inhibits the nitric oxide-mediated vasorelax
ation.